This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Novo Nordisk Healthcare Ag. Active years: 2015.
Company Filing History:
Years Active: 2015
Title: Innovations by Anders Dybdal Nielsen
Introduction
Anders Dybdal Nielsen is a notable inventor based in Ballerup, Denmark. He has made significant contributions to the field of pharmaceuticals, particularly in the formulation of polypeptides. His work focuses on enhancing the stability and efficacy of Factor VII polypeptide formulations.
Latest Patents
Anders Dybdal Nielsen holds a patent for "High concentration factor VII polypeptide formulations comprising an aromatic preservative and an antioxidant." This invention relates to pharmaceutical compositions that include at least 10 mg/mL of a Factor VII polypeptide, a buffering agent to maintain pH levels between 5.0 and 9.0, and specific concentrations of aromatic preservatives and antioxidants. The patent aims to improve the stability of these formulations while avoiding certain stabilizing agents.
Career Highlights
Anders is currently associated with Novo Nordisk Healthcare AG, a leading company in the healthcare sector. His work at Novo Nordisk focuses on innovative solutions in the pharmaceutical industry, contributing to advancements in treatment options.
Collaborations
Throughout his career, Anders has collaborated with notable colleagues, including Christian Rischel and Michael Bech Jensen. These collaborations have fostered a productive environment for innovation and research.
Conclusion
Anders Dybdal Nielsen's contributions to pharmaceutical formulations highlight his expertise and commitment to advancing medical science. His innovative work continues to impact the field positively.